News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,470 Results
Type
Article (87057)
Company Profile (704)
Press Release (767695)
Multimedia
Podcasts (156)
Webinars (20)
Section
Business (232908)
Career Advice (4134)
Deals (39771)
Drug Delivery (131)
Drug Development (91150)
Employer Resources (200)
FDA (18215)
Job Trends (17375)
News (397025)
Policy (39857)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (123)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (193)
Approvals (18183)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (416)
Cancer (3293)
Cardiovascular disease (263)
Career advice (3543)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (602)
Cervical cancer (26)
Clinical research (74598)
Collaboration (1182)
Company closure (4)
Compensation (789)
Complete response letters (42)
COVID-19 (2919)
CRISPR (71)
C-suite (417)
Cystic fibrosis (126)
Data (3359)
Decentralized trials (2)
Denatured (56)
Depression (84)
Diabetes (390)
Diagnostics (7012)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (162)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98431)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131731)
Executive appointments (933)
FDA (20265)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1059)
Gene editing (154)
Generative AI (42)
Gene therapy (475)
GLP-1 (964)
Government (5305)
Grass and pollen (7)
Guidances (322)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3126)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (141)
Interviews (813)
IPO (17910)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (611)
Leadership (27)
Legal (10140)
Liver cancer (87)
Longevity (12)
Lung cancer (456)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (499)
MASH (106)
Medical device (14774)
Medtech (14785)
Mergers & acquisitions (22637)
Metabolic disorders (1000)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2435)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (52)
Obesity (507)
Opinion (298)
Ovarian cancer (108)
Pain (136)
Pancreatic cancer (136)
Parkinson's disease (208)
Partnered (26)
Patents (353)
Patient recruitment (206)
Peanut (55)
People (65867)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23007)
Phase II (32383)
Phase III (24396)
Pipeline (2177)
Policy (263)
Postmarket research (3554)
Preclinical (10397)
Press Release (72)
Prostate cancer (160)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (554)
Real estate (7403)
Recruiting (76)
Regulatory (27406)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (111)
Series A (176)
Series B (127)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (76)
The Weekly (98)
Vaccines (955)
Venture capital (62)
Weight loss (346)
Women's health (53)
Worklife (20)
Date
Today (135)
Last 7 days (724)
Last 30 days (2636)
Last 365 days (33866)
2025 (21009)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50641)
Australia (8896)
California (8350)
Canada (2542)
China (763)
Colorado (357)
Connecticut (372)
Delaware (224)
Europe (116272)
Florida (1247)
Georgia (284)
Hawaii (3)
Idaho (67)
Illinois (767)
India (35)
Indiana (407)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1164)
Massachusetts (6353)
Michigan (284)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (91)
New Hampshire (75)
New Jersey (2311)
New Mexico (31)
New York (2301)
North Carolina (1297)
North Dakota (10)
Northern California (3658)
Ohio (267)
Oklahoma (17)
Oregon (48)
Pennsylvania (1780)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3136)
Tennessee (136)
Texas (1281)
United States (31263)
Utah (244)
Virginia (226)
Washington D.C. (80)
Washington State (722)
West Virginia (4)
Wisconsin (89)
There are 855,470 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Schrödinger Cans Early-Stage Blood Cancer Drug After Two Patient Deaths
After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be “difficult,” according to Schrödinger, whose stock dropped
17.5%
before the opening bell on Thursday.
August 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
2025 Chikungunya Outbreak: A Global Health Challenge
August 14, 2025
·
7 min read
Layoff Tracker
Abata Shuts Down Amid Fundraising Difficulties
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 14, 2025
·
186 min read
·
BioSpace Editorial Staff
Inflammatory bowel disease
CytomX Reports Treatment-Related Patient Death in Phase I Colorectal Cancer Study
The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” according to CytomX.
August 14, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis
Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy VE202 failed to demonstrate significant response rates in patients with ulcerative colitis.
August 14, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Tarries on Tariffs Again, Delays Plans by Weeks: Report
Citing other priorities—such as the upcoming U.S.-Russia summit—four anonymous sources claim that pharma tariffs could still be weeks away, according to
Reuters
.
August 14, 2025
·
2 min read
·
Tristan Manalac
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy changes with Aaron Cummings and Anne Li of Brownstein Hyatt Farber Schreck.
August 14, 2025
·
1 min read
·
Lori Ellis
Press Releases
Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma
August 14, 2025
·
6 min read
Press Releases
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
August 14, 2025
·
5 min read
Press Releases
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
August 14, 2025
·
17 min read
1 of 85,547
Next
